Rhythm Pharmaceuticals Inc (RYTM)
53.10
+4.09
(+8.35%)
USD |
NASDAQ |
Nov 04, 12:57
Rhythm Pharmaceuticals Price to Book Value: 82.51 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 76.16 |
| October 31, 2024 | 74.17 |
| October 30, 2024 | 76.98 |
| October 29, 2024 | 76.98 |
| October 28, 2024 | 76.81 |
| October 25, 2024 | 75.44 |
| October 24, 2024 | 77.24 |
| October 23, 2024 | 76.17 |
| October 22, 2024 | 76.34 |
| October 21, 2024 | 77.99 |
| October 18, 2024 | 79.01 |
| October 17, 2024 | 79.29 |
| October 16, 2024 | 81.30 |
| October 15, 2024 | 78.33 |
| October 14, 2024 | 78.07 |
| October 11, 2024 | 77.41 |
| October 10, 2024 | 74.54 |
| October 09, 2024 | 74.15 |
| October 08, 2024 | 74.73 |
| October 07, 2024 | 73.34 |
| October 04, 2024 | 77.12 |
| October 03, 2024 | 75.49 |
| October 02, 2024 | 79.26 |
| October 01, 2024 | 80.44 |
| September 30, 2024 | 81.41 |
| Date | Value |
|---|---|
| September 27, 2024 | 79.79 |
| September 26, 2024 | 79.45 |
| September 25, 2024 | 81.19 |
| September 24, 2024 | 79.62 |
| September 23, 2024 | 79.34 |
| September 20, 2024 | 82.04 |
| September 19, 2024 | 84.76 |
| September 18, 2024 | 83.35 |
| September 17, 2024 | 82.62 |
| September 16, 2024 | 76.95 |
| September 13, 2024 | 77.10 |
| September 12, 2024 | 76.62 |
| September 11, 2024 | 76.62 |
| September 10, 2024 | 76.28 |
| September 09, 2024 | 78.72 |
| September 06, 2024 | 76.53 |
| September 05, 2024 | 75.01 |
| September 04, 2024 | 72.86 |
| September 03, 2024 | 71.40 |
| August 30, 2024 | 73.48 |
| August 29, 2024 | 71.63 |
| August 28, 2024 | 72.08 |
| August 27, 2024 | 73.70 |
| August 26, 2024 | 77.69 |
| August 23, 2024 | 71.66 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6669
Minimum
May 19 2022
84.76
Maximum
Sep 19 2024
11.78
Average
5.014
Median
Dec 09 2022
Price to Book Value Benchmarks
| Eli Lilly and Co | 53.89 |
| TG Therapeutics Inc | 21.65 |
| Regeneron Pharmaceuticals Inc | 3.148 |
| Mirum Pharmaceuticals Inc | 8.542 |
| Moderna Inc | 1.775 |
Price to Book Value Related Metrics
| PS Ratio | 31.07 |
| PEG Ratio | -0.3699 |
| Price | 53.10 |
| Earnings Yield | -8.21% |
| Market Cap | 3.246B |
| PEGY Ratio | -0.3699 |